{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:30:16Z","timestamp":1762421416697,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.omtm.2020.10.015","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T10:25:56Z","timestamp":1603448756000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A Methodology for Assessing Tumor Clonality of Adult T Cell Leukemia\/Lymphoma"],"prefix":"10.1016","volume":"19","author":[{"given":"Tomohiro","family":"Yamakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-7312","authenticated-orcid":false,"given":"Naoki","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Kosai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.10.015_bib1","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/S1470-2045(11)70335-7","article-title":"Genetic heterogeneity and cancer drug resistance","volume":"13","author":"Turner","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omtm.2020.10.015_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omtm.2020.10.015_bib3","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1200\/EDBK_175524","article-title":"Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?","volume":"37","author":"El-Deiry","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.omtm.2020.10.015_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41587-019-0364-z","article-title":"A community effort to create standards for evaluating tumor subclonal reconstruction","volume":"38","author":"Salcedo","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2020.10.015_bib5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T\u00a0cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.10.015_bib6","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","article-title":"HTLV-1-infected T\u00a0cells contain a single integrated provirus in natural infection","volume":"120","author":"Cook","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.10.015_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtm.2020.10.015_bib8","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.10.015_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/gm568","article-title":"Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites","volume":"6","author":"Firouzi","year":"2014","journal-title":"Genome Med."},{"key":"10.1016\/j.omtm.2020.10.015_bib10","doi-asserted-by":"crossref","first-page":"28324","DOI":"10.1038\/srep28324","article-title":"Application of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome","volume":"6","author":"Miyazato","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2020.10.015_bib11","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2014-02-553602","article-title":"The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia\/lymphoma","volume":"123","author":"Cook","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.10.015_bib12","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/jvi.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.10.015_bib13","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/leu.2017.260","article-title":"Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality","volume":"31","author":"Artesi","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2020.10.015_bib14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.celrep.2019.09.016","article-title":"The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach","volume":"29","author":"Katsuya","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2020.10.015_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12185-020-02935-5","article-title":"A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in\u00a0vivo","volume":"112","author":"Saito","year":"2020","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.omtm.2020.10.015_bib16","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1093\/nar\/gkr140","article-title":"A method to sequence and quantify DNA integration for monitoring outcome in gene therapy","volume":"39","author":"Brady","year":"2011","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:25Z","timestamp":1762421125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120302199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":16,"alternative-id":["S2329050120302199"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.10.015","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Methodology for Assessing Tumor Clonality of Adult T Cell Leukemia\/Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}